Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Gene therapy for severe combined immunodeficiency: are we there yet?
Marina Cavazzana-Calvo, Alain Fischer
Marina Cavazzana-Calvo, Alain Fischer
Published June 1, 2007
Citation Information: J Clin Invest. 2007;117(6):1456-1465. https://doi.org/10.1172/JCI30953.
View: Text | PDF
Science in Medicine Article has an altmetric score of 6

Gene therapy for severe combined immunodeficiency: are we there yet?

  • Text
  • PDF
Abstract

Inherited and acquired diseases of the hematopoietic system can be cured by allogeneic hematopoietic stem cell transplantation. This treatment strategy is highly successful when an HLA-matched sibling donor is available, but if not, few therapeutic options exist. Gene-modified, autologous bone marrow transplantation can circumvent the severe immunological complications that occur when a related HLA-mismatched donor is used and thus represents an attractive alternative. In this review, we summarize the advantages and limitations associated with the use of gene therapy to cure SCID. Insertional mutagenesis and technological improvements aimed at increasing the safety of this strategy are also discussed.

Authors

Marina Cavazzana-Calvo, Alain Fischer

×

Total citations by year

Year: 2025 2024 2021 2020 2019 2018 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 Total
Citations: 1 1 1 1 1 1 2 6 2 4 3 4 9 6 9 4 55
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (55)

Title and authors Publication Year
Translation of unspliced retroviral genomic RNA in the host cell is regulated in both space and time
Leon-Diaz F, Chamontin C, Lainé S, Socol M, Bertrand E, Mougel M
The Journal of Cell Biology 2025
Differentiation ability of hematopoietic stem cells and mesenchymal stem cells isolated from human peripheral blood
Samundeshwari EL, Kattaru S, Kodavala S, Chandrasekhar C, Sarma PV
Frontiers in Cell and Developmental Biology 2024
A Multifaceted Approach to Optimizing AAV Delivery to the Brain for the Treatment of Neurodegenerative Diseases
Jonathan M Fischell, Paul S Fishman
Frontiers in neuroscience 2021
Successful Preclinical Development of Gene Therapy for Recombinase-Activating Gene-1-Deficient SCID
L Garcia-Perez, M van Eggermond, L van Roon, SA Vloemans, M Cordes, A Schambach, M Rothe, D Berghuis, C Lagresle-Peyrou, M Cavazzana, F Zhang, AJ Thrasher, D Salvatori, P Meij, A Villa, JJ Dongen, JJ Zwaginga, M van der Burg, HB Gaspar, A Lankester, FJ Staal, K Pike-Overzet
Molecular Therapy — Methods & Clinical Development 2020
Darwinian selection within an individual or somatic selection: facts and models
RA Veitia
Journal of Molecular Cell Biology 2019
ADA Deficiency: Evaluation of the Clinical and Laboratory Features and the Outcome
D Cagdas, PG Cetinkaya, B Karaatmaca, S Esenboga, C Tan, T Yılmaz, E Gümüş, S Barış, B Kuşkonmaz, TT Ozgur, P Bali, I Santisteban, D Orhan, A Yüce, D Cetinkaya, K Boztug, M Hershfield, O Sanal, İ Tezcan
Journal of Clinical Immunology 2018
Advances in gene therapy for muscular dystrophies
H Abdul-Razak, A Malerba, G Dickson
F1000Research 2016
Gene therapy for metabolic diseases
RJ Chandler, CP Venditti
Translational Science of Rare Diseases 2016
Towards in vivo amplification: Overcoming hurdles in the use of hematopoietic stem cells in transplantation and gene therapy
Murtaza S Nagree, Lucía López-Vásquez, Jeffrey A Medin
World journal of stem cells 2015
Insights into the nuclear export of murine leukemia virus intron-containing RNA
L Pessel-Vivares, L Houzet, S Lainé, M Mougel
RNA biology 2015
Characterization of Equine Infectious Anemia Virus Integration in the Horse Genome
Q Liu, XF Wang, J Ma, XJ He, XJ Wang, JH Zhou
Viruses 2015
Gene therapy for ocular diseases meditated by ultrasound and microbubbles (Review)
C Wan, F Li, H Li
Molecular medicine reports 2015
Assessing risk/benefit for trials using preclinical evidence: a proposal
J Kimmelman, V Henderson
Journal of medical ethics 2015
[Heterogeneity of hematopoietic stem cell]
Chen Chen, Sha Hao, Tao Cheng
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2015
No evidence of clonal dominance after transplant of HOXB4-expanded cord blood cells in a nonhuman primate model
KL Watts, BC Beard, BL Wood, GD Trobridge, RK Humphries, AB Adams, V Nelson, HP Kiem
Experimental Hematology 2014
MLV requires Tap/NXF1-dependent pathway to export its unspliced RNA to the cytoplasm and to express both spliced and unspliced RNAs
L Pessel-Vivares, M Ferrer, S Lainé, M Mougel
Retrovirology 2014
Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches
RJ Fairclough, MJ Wood, KE Davies
Nature Reviews Genetics 2013
The era of genomic medicine
K Davies
Clinical Medicine 2013
Gene therapy model of X-linked severe combined immunodeficiency using a modified foamy virus vector
S Horino, T Uchiyama, T So, H Nagashima, SL Sun, M Sato, A Asao, Y Haji, Y Sasahara, F Candotti, S Tsuchiya, S Kure, K Sugamura, N Ishii
PloS one 2013
Gene therapy for cardiovascular disease mediated by ultrasound and microbubbles
ZY Chen, Y Lin, F Yang, L Jiang, S Ge
Cardiovascular ultrasound 2013
Development of safer gene delivery systems to minimize the risk of insertional mutagenesis-related malignancies: a critical issue for the field of gene therapy
G Romano
ISRN Oncology 2012
Novel Cell and Gene Therapies for HIV
JA Hoxie, CH June
2012
Nanoscale Particles for Lung Delivery of siRNA
Nascimento TL, Hillaireau H, Fattal E
Journal of drug delivery science and technology 2012
Oligo/Polynucleotide-Based Gene Modification: Strategies and Therapeutic Potential
RG Sargent, S Kim, DC Gruenert
Oligonucleotides 2011
AAV and Compacted DNA Nanoparticles for the Treatment of Retinal Disorders: Challenges and Future Prospects
Z Han, SM Conley, MI Naash
Investigative ophthalmology & visual science 2011
Adipocytes as a vehicle for ex vivo gene therapy: Novel replacement therapy for diabetes and other metabolic diseases
M Kuroda, H Bujo, M Aso, Y Saito
Journal of Diabetes Investigation 2011
Recombinant Adeno-Associated Virus-Mediated Gene Transfer for the Potential Therapy of Adenosine Deaminase-Deficient Severe Combined Immune Deficiency
JN Silver, Melissa, T Conlon, P Cruz, AJ Wright, A Srivastava, TR Flotte
Human Gene Therapy 2011
Lentiviral vectors for immune cells targeting
S Froelich, A Tai, P Wang
Immunopharmacology and Immunotoxicology 2010
A self-inactivating lentiviral vector for SCID-X1 gene therapy that does not activate LMO2 expression in human T cells
S Zhou, D Mody, SS DeRavin, J Hauer, T Lu, Z Ma, SH Abina, JT Gray, MR Greene, M Cavazzana-Calvo, HL Malech, BP Sorrentino
Blood 2010
B cell-specific lentiviral gene therapy leads to sustained B-cell functional recovery in a murine model of X-linked agammaglobulinemia
HM Kerns, BY Ryu, BV Stirling, BD Sather, A Astrakhan, S Humblet-Baron, D Liggitt, DJ Rawlings
Blood 2010
The Biology of Allogeneic Hematopoietic Cell Resistance
JA Shizuru, D Bhattacharya, M Cavazzana-Calvo
Biology of Blood and Marrow Transplantation 2010
Retroviral Integration Site Selection
S Desfarges, A Ciuffi
Viruses 2010
Novel Viral Vector Systems for Gene Therapy
D Stone
Viruses 2010
Induction of Pluripotent Stem Cells from Human Third Molar Mesenchymal Stromal Cells*♦
Y Oda, Y Yoshimura, H Ohnishi, M Tadokoro, Y Katsube, M Sasao, Y Kubo, K Hattori, S Saito, K Horimoto, S Yuba, H Ohgushi
The Journal of biological chemistry 2010
Chromatin tethering and retroviral integration: Recent discoveries and parallels with DNA viruses
AM Meehan, EM Poeschla
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 2010
Biomolecular Structure and Modeling: Problem and Application Perspective
Schlick T
2010
Chronic Granulomatous Disease
SM Holland
Clinical Reviews in Allergy & Immunology 2009
Finding the needle in the hay stack: Hematopoietic stem cells in Fanconi anemia
LU Müller, DA Williams
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2009
Dystrophin delivery to muscles of mdx mice using lentiviral vectors leads to myogenic progenitor targeting and stable gene expression
E Kimura, S Li, P Gregorevic, BM Fall, JS Chamberlain
Molecular Therapy 2009
Stimulation of homology-directed gene targeting at an endogenous human locus by a nicking endonuclease
GP van Nierop, AA de Vries, M Holkers, KR Vrijsen, MA Gonçalves
Nucleic Acids Research 2009
Alphaviruses in Gene Therapy
K Lundstrom
Viruses 2009
Polyethylenimine-mediated gene delivery to the lung and therapeutic applications
Di Gioia S, Conese M
Drug design, development and therapy 2009
High Incidence of Leukemia after Stem-Cell Gene Therapy in Large Animals with a HOXB4-expressing Vector
Xiao-Bing Zhang, Brian C. Beard, Grant D. Trobridge, Brent L. Wood, George E. Sale, Reeteka Sud, R. Keith Humphries, Hans-Peter Kiem
Journal of Clinical Investigation 2008
Evolution of highly polymorphic T cell populations in siblings with the Wiskott-Aldrich Syndrome
MI Lutskiy, JY Park, SK Remold, E Remold-O'Donnell
PloS one 2008
Cell type differences in activity of the Streptomyces bacteriophage phiC31 integrase
C Maucksch, MK Aneja, E Hennen, A Bohla, F Hoffmann, M Elfinger, J Rosenecker, C Rudolph
Nucleic Acids Research 2008
Mutations in CHD7 in patients with CHARGE syndrome cause T-B + natural killer cell + severe combined immune deficiency and may cause Omenn-like syndrome
AR Gennery, MA Slatter, J Rice, LH Hoefsloot, D Barge, A McLean-Tooke, T Montgomery, JA Goodship, AD Burt, TJ Flood, M Abinun, AJ Cant, D Johnson
Clinical & Experimental Immunology 2008
Hepatocyte Growth Factor Enhances Engraftment and Function of Nonhuman Primate Islets
NM Fiaschi-Taesch, DM Berman, BM Sicari, KK Takane, A Garcia-Ocana, C Ricordi, NS Kenyon, AF Stewart
Diabetes 2008
Maintaining the silence: reflections on long-term RNAi
K Raemdonck, RE Vandenbroucke, J Demeester, NN Sanders, SC Smedt
Drug Discovery Today 2008
Correction of glycogenosis type 2 by muscle-specific lentiviral vector
E Richard, G Douillard-Guilloux, L Batista, C Caillaud
In vitro cellular & developmental biology. Animal 2008
Partially corrected X-linked severe combined immunodeficiency: long-term problems and treatment options
SS Ravin, HL Malech
Immunologic Research 2008
Transporter Molecules influence the Gene Expression in HeLa Cells
Waldeck W, Pipkorn R, Korn B, Mueller G, Schick M, Tóth K, Wiessler M, Didinger B, Braun K
International journal of medical sciences 2008
Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy
Alessandro Aiuti, Barbara Cassani, Grazia Andolfi, Massimiliano Mirolo, Luca Biasco, Alessandra Recchia, Fabrizia Urbinati, Cristina Valacca, Samantha Scaramuzza, Memet Aker, Shimon Slavin, Matteo Cazzola, Daniela Sartori, Alessandro Ambrosi, Clelia Di Serio, Maria Grazia Roncarolo, Fulvio Mavilio, and Claudio Bordignon.
Journal of Clinical Investigation 2007
Therapeutic application of RNAi: Is mRNA targeting finally ready for prime-time?
Dirk Grimm and Mark A. Kay
Journal of Clinical Investigation 2007
Cellular genetic tools to control oncolytic adenoviruses for virotherapy of cancer
DM Nettelbeck
Journal of Molecular Medicine 2007
Characterization of a natural heterodimer between MLV genomic RNA and the SD' retroelement generated by alternative splicing
S Maurel, L Houzet, EL Garcia, A Telesnitsky, M Mougel
RNA (New York, N.Y.) 2007

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 patents
Referenced in 15 Wikipedia pages
237 readers on Mendeley
See more details